CCAAT/enhancer binding proteins α and β regulate the tumor necrosis factor receptor 1 gene promoter

Molecular Immunology

Volumn 46, Issue 13, 2009, Pages 2706-2713

  Bristol, Jillian A ^a   Morrison, Thomas E ^b   Kenney, Shannon C ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokine; Gene regulation; Inflammation; siRNA; Transcription factor

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; CYTOKINE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ARTICLE; AUTOREGULATION; BINDING SITE; CANCER CELL CULTURE; CELL STRAIN HEK293; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE AMPLIFICATION; HELA CELL; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; REGULATORY MECHANISM; REPORTER GENE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

BASE SEQUENCE; BINDING SITES; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CHROMATIN IMMUNOPRECIPITATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; IMMUNOBLOTTING; MUTAGENESIS, SITE-DIRECTED; OLIGONUCLEOTIDES; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECOMBINANT FUSION PROTEINS; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 67650360783     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.05.024     Document Type: Article

References (43)

1. Baillie J., Sahlender D.A., and Sinclair J.H. Human cytomegalovirus infection inhibits tumor necrosis factor alpha (TNF-alpha) signaling by targeting the 55-kilodalton TNF-alpha receptor. J. Virol. 77 (2003) 7007-7016
2. Benedict C.A., and Ware C.F. Virus targeting of the tumor necrosis factor superfamily. Virology 289 (2001) 1-5
3. Bertazza L., and Mocellin S. Tumor necrosis factor (TNF) biology and cell death. Front. Biosci. 13 (2008) 2736-2743
4. Cardinaux J.R., Allaman I., and Magistretti P.J. Pro-inflammatory cytokines induce the transcription factors C/EBPbeta and C/EBPdelta in astrocytes. Glia 29 (2000) 91-97
5. Chen C., Dudenhausen E., Chen H., Pan Y.X., Gjymishka A., and Kilberg M.S. Amino-acid limitation induces transcription from the human C/EBPbeta gene via an enhancer activity located downstream of the protein coding sequence. Biochem. J. 391 (2005) 649-658
6. Chen G., and Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 296 (2002) 1634-1635
7. Di-Poi N., Desvergne B., Michalik L., and Wahli W. Transcriptional repression of peroxisome proliferator-activated receptor beta/delta in murine keratinocytes by CCAAT/enhancer-binding proteins. J. Biol. Chem. 280 (2005) 38700-38710
8. Friedman A.D. Transcriptional control of granulocyte and monocyte development. Oncogene 26 (2007) 6816-6828
9. Gorman C.M., Moffat L.F., and Howard B.H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2 (1982) 1044-1051
10. Hasselgren P.O. Ubiquitination, phosphorylation, and acetylation-triple threat in muscle wasting. J. Cell. Physiol. 213 (2007) 679-689
11. Huang J., Liao G., Chen H., Wu F.Y., Hutt-Fletcher L., Hayward G.S., et al. Contribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cells. J. Virol. 80 (2006) 1098-1109
12. Imre G., Gekeler V., Leja A., Beckers T., and Boehm M. Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation. Cancer Res. 66 (2006) 5409-5418
13. Jain R., Police S., Phelps K., and Pekala P.H. Tumour necrosis factor-alpha regulates expression of the CCAAT-enhancer-binding proteins (C/EBPs) alpha and beta and determines the occupation of the C/EBP site in the promoter of the insulin-responsive glucose-transporter gene in 3T3-L1 adipocytes. Biochem. J. 338 Pt 3 (1999) 737-743
14. Jeong H.G., Pokharel Y.R., Han E.H., and Kang K.W. Induction of cyclooxygenase-2 by ginsenoside rd via activation of CCAAT-enhancer binding proteins and cyclic AMP response binding protein. Biochem. Biophys. Res. Commun. 359 (2007) 51-56
15. Jones R.J., Dickerson S., Bhende P.M., Delecluse H.J., and Kenney S.C. Epstein-Barr virus lytic infection induces retinoic acid-responsive genes through induction of a retinol-metabolizing enzyme. DHRS9 J. Biol. Chem. 282 (2007) 8317-8324
16. Kaminski R., Kozar K., Niderla J., Grzela T., Wilczynski G., Skierski J.S., et al. Demethylating agent 5-aza-2'-deoxycytidine enhances expression of TNFRI and promotes TNF-mediated apoptosis in vitro and in vivo. Oncol. Rep. 12 (2004) 509-516
17. Kemper O., and Wallach D. Cloning and partial characterization of the promoter for the human p55 tumor necrosis factor (TNF) receptor. Gene 134 (1993) 209-216
18. Khanna-Gupta A. Sumoylation and the function of CCAAT enhancer binding protein alpha (C/EBP alpha). Blood Cells Mol. Dis. 41 (2008) 77-81
19. Kim S., Moon S.M., Kim Y.S., Kim J.J., Ryu H.J., Kim Y.J., et al. TNFR1 promoter -329G/T polymorphism results in allele-specific repression of TNFR1 expression. Biochem. Biophys. Res. Commun. 368 (2008) 395-401
20. Kost E.R., Mutch D.G., and Herzog T.J. Interferon-gamma and tumor necrosis factor-alpha induce synergistic cytolytic effects in ovarian cancer cell lines-roles of the TR60 and TR80 tumor necrosis factor receptors. Gynecol. Oncol. 72 (1999) 392-401
21. Liang L., and Roizman B. Herpes simplex virus 1 precludes replenishment of the short-lived receptor of tumor necrosis factor alpha by virion host shutoff-dependent degradation of its mRNA. J. Virol. 80 (2006) 7756-7759
22. Lipsky P.E., van der Heijde D.M., St Clair E.W., Furst D.E., Breedveld F.C., Kalden J.R., et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. N. Engl. J. Med. 343 (2000) 1594-1602
23. MacEwan D.J. TNF receptor subtype signalling: differences and cellular consequences. Cell Signal. 14 (2002) 477-492
24. Mocellin S., and Nitti D. TNF and cancer: the two sides of the coin. Front. Biosci. 13 (2008) 2774-2783
25. Morrison T.E., Mauser A., Klingelhutz A., and Kenney S.C. Epstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1. J. Virol. 78 (2004) 544-549
26. Nerlov C. The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol. 17 (2007) 318-324
27. Nerlov C. C/EBPs: recipients of extracellular signals through proteome modulation. Curr. Opin. Cell Biol. 20 (2008) 180-185
28. Osada S., Yamamoto H., Nishihara T., and Imagawa M. DNA binding specificity of the CCAAT/enhancer-binding protein transcription factor family. J. Biol. Chem. 271 (1996) 3891-3896
29. Pham T.H., Langmann S., Schwarzfischer L., El Chartouni C., Lichtinger M., Klug M., et al. CCAAT enhancer-binding protein beta regulates constitutive gene expression during late stages of monocyte to macrophage differentiation. J. Biol. Chem. 282 (2007) 21924-21933
30. Poli V. The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J. Biol. Chem. 273 (1998) 29279-29282
31. Pope R.M., Leutz A., and Ness S.A. C/EBP beta regulation of the tumor necrosis factor alpha gene. J. Clin. Invest. 94 (1994) 1449-1455
32. Popkin D.L., and Virgin H.W.4t. Murine cytomegalovirus infection inhibits tumor necrosis factor alpha responses in primary macrophages. J. Virol. 77 (2003) 10125-10130
33. Ramji D.P., and Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 365 (2002) 561-575
34. Salmenpera P., Hamalainen S., Hukkanen M., and Kankuri E. Interferon-gamma induces C/EBP beta expression and activity through MEK/ERK and p38 in T84 colon epithelial cells. Am. J. Physiol. Cell Physiol. 284 (2003) C1133-C1139
35. Schling P., Rudolph C., Heimerl S., Fruth S., and Schmitz G. Expression of tumor necrosis factor alpha and its receptors during cellular differentiation. Cytokine 33 (2006) 239-245
36. Schuster M.B., and Porse B.T. C/EBPalpha: a tumour suppressor in multiple tissues?. Biochim. Biophys. Acta 1766 (2006) 88-103
37. Trefzer U., Brockhaus M., Lotscher H., Parlow F., Budnik A., Grewe M., et al. The 55-kD tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor-alpha and by ultraviolet B radiation. J. Clin. Invest. 92 (1993) 462-470
38. Wallach D., Varfolomeev E.E., Malinin N.L., Goltsev Y.V., Kovalenko A.V., and Boldin M.P. Tumor necrosis factor receptor and fas signaling mechanisms. Annu. Rev. Immunol. 17 (1999) 331-367
39. Wiper-Bergeron N., Wu D., Pope L., Schild-Poulter C., and Hache R.J. Stimulation of preadipocyte differentiation by steroid through targeting of an HDAC1 complex. EMBO J. 22 (2003) 2135-2145
40. Xu M., Nie L., Kim S.H., and Sun X.H. STAT5-induced id-1 transcription involves recruitment of HDAC1 and deacetylation of C/EBPbeta. EMBO J. 22 (2003) 893-904
41. Yin M., Yang S.Q., Lin H.Z., Lane M.D., Chatterjee S., and Diehl A.M. Tumor necrosis factor alpha promotes nuclear localization of cytokine-inducible CCAAT/enhancer binding protein isoforms in hepatocytes. J. Biol. Chem. 271 (1996) 17974-17978
42. Zheng L., Bidere N., Staudt D., Cubre A., Orenstein J., Chan F.K., et al. Competitive control of independent programs of tumor necrosis factor receptor-induced cell death by TRADD and RIP1. Mol. Cell. Biol. 26 (2006) 3505-3513
43. Zuo Y., Qiang L., and Farmer S.R. Activation of CCAAT/enhancer-binding protein (C/EBP) alpha expression by C/EBP beta during adipogenesis requires a peroxisome proliferator-activated receptor-gamma-associated repression of HDAC1 at the C/ebp alpha gene promoter. J. Biol. Chem. 281 (2006) 7960-7967